A woman is running on treadmill while a healthcare professional looks on
Can exercise help people with cancer improve treatment outcomes?

Dr Kerry Courneya is a CCS-funded researcher at the University of Alberta and a leader in the field of exercise and cancer research. He currently has a CCS grant to study the impact of exercise on people with rectal cancer. We asked him about his latest CCS-supported project and his career in research. CCS: What is the research focus of your lab? KC: My research program focuses on exercise and physical activity in cancer patients and the different ways that exercise may help in the fight against cancer. We study whether exercise during treatment can help patients to manage their symptoms and maintain their quality of life, and whether it can improve long-term survival and reduce recurrence after treatment. We also study whether exercise may help patients to complete their treatment and get a better response.

Dietary supplements on a spoon
Dietary supplement may make cancer drug more effective

One of the oldest cancer drugs in use is methotrexate. It is used to treat a variety of solid and blood cancers, but it can also cause side effects that, in some cases, are so severe that treatment needs to be stopped.

Your trusted source for the most up-to-date cancer statistics in Canada

For more than 30 years, Canadian Cancer Statistics has provided comprehensive, up-to-date cancer statistics for Canada. Developed collaboratively by the Canadian Cancer Society, Public Health Agency of Canada and Statistics Canada, a special report on cancer incidence by stage was released June 13, 2018.

screenshot from video showing doctor and patient
How the HPV vaccine works

Watch video

animation of a CAR-T cell interacting with a target protein on a cancer cell
How CAR-T cells work to fight cancer

Watch video

cartoon of cancer stem cell resisting treatment
The challenges behind the fight against cancer

Watch video

More and more young adults being diagnosed with colon cancer

Ryan Halladay was just 39 years old when he was diagnosed with colorectal cancer. He is part of a puzzling new phenomenon seen in hospitals across North America – as the rate of colon cancer in people over the age of 50 is declining, the incidence of the disease is rising rapidly in younger adults. Doctors and patient advocates are now trying to raise awareness and encourage young adults and doctors to pay attention to suspicious symptoms. Read more in an article from The Globe and Mail.

Contraceptive pill linked to lower risk of ovarian cancer

Women taking the oral contraceptive pill that includes both estrogen and progesterone are at a lower risk of developing ovarian cancer, according to researchers in a new study. The findings are based on data collected from over 1.8 million women in a national Danish health database between 1995 and 2014. The researchers found that women who had used the contraceptive pill with both hormones were 34% less likely to get ovarian cancer than women who had not used the pill. Further the longer women…

The risks of alternative cancer treatments

A cancer diagnosis can prompt patients to turn to alternative therapies, such as acupuncture, herbal supplements and yoga, to guide their treatment. If chosen properly, these complementary treatments can be integrated with conventional treatments like chemotherapy or radiation to help reduce side effects and improve quality of life. However, replacing conventional medical treatments with these alternative therapies can be harmful. A new study found that the risk of death was 2.5 times higher…

Exploring a cancer paradox

Researchers have long known that mutations or changes in the DNA blueprint of our cells contribute to the development of cancer. With recent technological advancements, researchers have been surprised to find many of these so-called cancer-causing mutations in healthy cells in people who don’t have cancer. Why these mutations lead to cancer in some cells and not others is one of the most perplexing questions in the field of cancer biology. Read more in an article from The New York Times.

High-dose radiation improves survival in metastatic cancer

A new clinical trial led by researchers in London, Canada has shown that high-dose radiation can improve survival in patients whose cancer had spread to 5 areas or less. The study looked at a technique called stereotactic ablative radiotherapy (SABR), which delivers a very high dose to a precise location. Patients who received the standard treatment of chemotherapy or radiation plus SABR lived 13 months longer than patients who received the standard treatment only. Five years after the…

Helping Indigenous patients with cancer navigate their care

Indigenous patients with cancer face many barriers in getting the care that they need. To address these challenges, some cancer centres have a dedicated patient navigation specialist to advocate for Indigenous patients and help them get the best care possible. These navigators support patients by accompanying them to medical visits, connecting them with elders and helping them access support programs and services. Read more in a story from The Globe and Mail.